Implementation of the 2013 American College of Cardiology/American Heart Association Blood Cholesterol Guideline Including Data From the Improved Reduction of Outcomes: Vytorin Efficacy International Trial.

PubWeight™: 0.75‹?›

🔗 View Article (PMC 4600404)

Published in Rev Cardiovasc Med on January 01, 2015

Authors

Boback Ziaeian, John Dinkler, Karol Watson1

Author Affiliations

1: Division of Cardiology, David Geffen School of Medicine at UCLA, Los Angeles, CA; Jonathan and Karin Fielding School of Public Health at UCLA, Los Angeles, CA; UCLA Barbra Streisand Women's Heart Health Program, Los Angeles, CA.

Articles cited by this

Third Report of the National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III) final report. Circulation (2002) 76.93

Heart disease and stroke statistics--2013 update: a report from the American Heart Association. Circulation (2012) 30.79

General cardiovascular risk profile for use in primary care: the Framingham Heart Study. Circulation (2008) 26.42

The effects of lowering LDL cholesterol with statin therapy in people at low risk of vascular disease: meta-analysis of individual data from 27 randomised trials. Lancet (2012) 17.29

2013 ACC/AHA guideline on the treatment of blood cholesterol to reduce atherosclerotic cardiovascular risk in adults: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines. J Am Coll Cardiol (2013) 17.18

Development and validation of improved algorithms for the assessment of global cardiovascular risk in women: the Reynolds Risk Score. JAMA (2007) 15.32

American College of Sports Medicine position stand. Quantity and quality of exercise for developing and maintaining cardiorespiratory, musculoskeletal, and neuromotor fitness in apparently healthy adults: guidance for prescribing exercise. Med Sci Sports Exerc (2011) 14.42

Coronary artery calcium score combined with Framingham score for risk prediction in asymptomatic individuals. JAMA (2004) 9.99

2013 ACC/AHA guideline on the assessment of cardiovascular risk: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines. J Am Coll Cardiol (2013) 8.90

Application of new cholesterol guidelines to a population-based sample. N Engl J Med (2014) 8.22

Criteria for evaluation of novel markers of cardiovascular risk: a scientific statement from the American Heart Association. Circulation (2009) 8.11

Walking compared with vigorous exercise for the prevention of cardiovascular events in women. N Engl J Med (2002) 7.77

C-reactive protein and parental history improve global cardiovascular risk prediction: the Reynolds Risk Score for men. Circulation (2008) 7.33

Statins for the primary prevention of cardiovascular disease. Cochrane Database Syst Rev (2013) 5.57

Mechanisms of acute coronary syndromes and their implications for therapy. N Engl J Med (2013) 5.43

Exercise type and intensity in relation to coronary heart disease in men. JAMA (2002) 4.69

2013 AHA/ACC guideline on lifestyle management to reduce cardiovascular risk: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines. J Am Coll Cardiol (2013) 3.35

Physical activity and coronary heart disease in men: The Harvard Alumni Health Study. Circulation (2000) 2.70

Optimizing statin treatment for primary prevention of coronary artery disease. Ann Intern Med (2010) 2.41

Low-risk diet and lifestyle habits in the primary prevention of myocardial infarction in men: a population-based prospective cohort study. J Am Coll Cardiol (2014) 1.91

Three reasons to abandon low-density lipoprotein targets: an open letter to the Adult Treatment Panel IV of the National Institutes of Health. Circ Cardiovasc Qual Outcomes (2012) 1.36

Cardiovascular risk and statin use in the United States. Ann Fam Med (2014) 1.13